FARP2, HDLBP and PASK are downregulated in a patient With autism and 2q37.3 deletion syndrome

American Journal of Medical Genetics, Part A

Volumn 149, Issue 5, 2009, Pages 952-959

  Felder, Barbel ^a   Radlwimmer, Bernhard ^a   Benner, Axel ^a   Mincheva, Antoaneta ^a   Tödt, Grischa ^a   Beyer, Kim S ^a   Schuster, Claudia ^a,c   Bölte, Sven ^b,d   Schmötzer, Gabriele ^b   Klauck, Sabine M ^a   Poustka, Fritz ^b   Lichter, Peter ^a   Poustka, Annemarie ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Autism; Chromosome 2; Terminal deletion 2q

Indexed keywords

GLYPICAN 1; KINESIN 1; KINESIN 1A; PLECKSTRIN; PLECKSTRIN DOMAIN PROTEIN 2; RNA; UNCLASSIFIED DRUG;

ADULT; ALBRIGHT SYNDROME; ANAMNESIS; ARTICLE; AUTISM; CASE REPORT; CHROMOSOME 2Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FERM GENE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE EXPRESSION; HUMAN; LYMPHOBLASTOID CELL LINE; MALE; MICROSATELLITE MARKER; NEUROPSYCHIATRY; PHENOTYPE; PRIORITY JOURNAL; PROLINE ALANINE RICH STE20 RELATED KINASE GENE; RHOGEF GENE; RNA TRANSLATION; SKELETON MALFORMATION; VIGILIN GENE;

ADULT; AUTISTIC DISORDER; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 2; DOWN-REGULATION; GENE EXPRESSION REGULATION; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; MALE; MICROSATELLITE REPEATS; PROTEIN-SERINE-THREONINE KINASES; RNA-BINDING PROTEINS; SYNDROME;

EID: 66849093887     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.32779     Document Type: Article

References (45)

1. Aldred MA, Sanford RO, Thomas NS, Barrow MA, Wilson LC, Brueton LA, Bonaglia MC, Hennekam RC, Eng C, Dennis NR, Trembath RC. 2004. Molecular analysis of 20 patients with 2q37.3 monosomy: definition of minimum deletion intervals for key phenotypes. J Med Genet 41:433-439.
2. Bearden CE, Jawad AF, Lynch DR, Sokol S, Kanes SJ, McDonald-McGinn DM, Saitta SC, Harris SE, Moss E, Wang PP, Zackai E, Emanuel BS, Simon TJ. 2004. Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome. Am J Psychiatry 161:1700-1702.
3. Casas KA, Mononen TK, Mikail CN, Hassed SJ, Li S, Mulvihill JJ, Lin HJ, Falk RE. 2004. Chromosome 2q terminal deletion: report of 6 new patients and review ofphenotype-breakpoint correlations in 66 individuals. Am J Med Genet 130A:331-339.
4. Chassaing N, De Mas P, Tauber M, Vincent MC, Julia S, Bourrouillou G, Calvas P, Bieth E. 2004. Molecular characterization of a cryptic 2q37 deletion in a patient with Albright hereditary osteodystrophy-like phenotype. Am J Med Genet 128A:410-413.
5. Falk RE, Casas KA. 2007. Chromosome 2q37 deletion: clinical and molecular aspects. Am J Med Genet C Semin Med Genet 145:357-371.
6. Fiegler H, Carr P, Douglas EJ, Burford DC, Hunt S, Scott CE, Smith J, Vetrie D, Gorman P, Tomlinson IP, Carter NP. 2003. DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer 36:361 -374.
7. Ghaziuddin M, Burmeister M. 1999. Deletion of chromosome 2q37 and autism: a distinct subtype? J Autism Dev Disord 29:259-263.
8. Goldstein LS, Yang Z. 2000. Microtubule-based transport systems in neurons: the roles ofkinesins and dyneins. Annu RevNeurosci 23:39-71.
9. Gray J, Yeo GS, Cox JJ, Morton J, Adlam AL, Keogh JM, Yanovski JA, El Gharbawy A, Han JC, Tung YC, Hodges JR, Raymond FL, O'Rahilly S, Farooqi IS. 2006. Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss ofone copy ofthe brain-derived neurotrophic factor (BDNF) gene. Diabetes 55:3366-3371.
10. Hirokawa N, Takemura R. 2004. Kinesin superfamily proteins and their various functions and dynamics. Exp Cell Res 301:50-59.
11. Hofer T, Spielmann P, Stengel P, Stier B, Katschinski DM, Desbaillets I, Gassmann M, Wenger RH. 2001. Mammalian PASKIN, a PAS-serine/ threonine kinase related to bacterial oxygen sensors. Biochem Biophys Res Commun 288:757-764.
12. IMGSAC. 2001. A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am J Hum Genet 69:570-581.
13. Kanamori H, Dodson RE, Shapiro DJ. 1998. In vitro genetic analysis ofthe RNA binding site ofvigilin, a multi-KH-domain protein. Mol Cell Biol 18:3991 -4003.
14. Katschinski DM, Marti HH, Wagner KF, Shibata J, Eckhardt K, Martin F, Depping R, Paasch U, Gassmann M, Ledermann B, Desbaillets I, Wenger RH. 2003. Targeted disruption ofthe mouse PAS domain serine/threonine kinase PASKIN. Mol Cell Biol 23:6780-6789.
15. Knight SJ, Lese CM, Precht KS, Kuc J, Ning Y, Lucas S, Regan R, Brenan M, Nicod A, Lawrie NM, Cardy DL, Nguyen H, Hudson TJ, Riethman HC, Ledbetter DH, Flint J. 2000. An optimized set ofhuman telomere clones for studying telomere integrity and architecture. Am J Hum Genet 67:320-332.
16. Kubo T, Yamashita T, Yamaguchi A, Sumimoto H, Hosokawa K, Tohyama M. 2002. A novel FERM domain including guanine nucleotide exchange factor is involved in Rac signaling and regulates neurite remodeling. J Neurosci 22:8504-8513.
17. Leiserson WM, Harkins EW, Keshishian H. 2000. Fray, a Drosophila serine/ threonine kinase homologous to mammalian PASK, is required for axonal ensheathment. Neuron 28:793-806.
18. Z, Van Aelst L, Cline HT. 2000. Rho GTPases regulate distinct aspects of dendritic arbor growth in Xenopus central neurons in vivo. Nat Neurosci 3:217-225.
19. Lichter P, Tang CJ, Call K, Hermanson G, Evans GA, Housman D, Ward DC. 1990. High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science 247:64-69.
20. LitwackED, Ivins JK, Kumbasar A, Paine-Saunders S, Stipp CS, Lander AD. 1998. Expression of the heparan sulfate proteoglycan glypican-1 in the developing rodent. Dev Dyn 211:72-87.
21. Lord C, Rutter M, Le Couteur A. 1994. Autism Diagnostic Interview- Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24:659-685.
22. Lord C, Risi S, Lambrecht L, Cook EH Jr, Leventhal BL, DiLavore PC, Pickles A, Rutter M. 2000. The autism diagnostic observation schedule- generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 30:205-223.
23. Lukusa T, Vermeesch JR, Holvoet M, Fryns JP, Devriendt K. 2004. Deletion 2q37.3 and autism: molecular cytogenetic mapping of the candidate region for autistic disorder. Genet Couns 15:293-301.
24. Luo L. 2000. Rho GTPases in neuronal morphogenesis. Nat Rev Neurosci 1:173-180.
25. MillerSA, Dykes DD, PoleskyHF. 1988. Asimplesaltingoutprocedurefor extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
26. Neitzel H. 1986. A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum Genet 73:320-3326.
27. Paylor R, Glaser B, Mupo A, Ataliotis P, Spencer C, Sobotka A, Sparks C, Choi CH, Oghalai J, Curran S, Murphy KC, Monks S, Williams N, O'Donovan MC, Owen MJ, Scambler PJ, Lindsay E. 2006. Tbx1 hap- loinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc Natl Acad Sci USA 103:7729-7734.
28. Pescucci C, Meloni I, Bruttini M, Ariani F, Longo I, Mari F, Canitano R, Hayek G, Zappella M, Renieri A. 2003. Chromosome 2 deletion encompassing the MAP2 gene in a patient with autism and Rett-like features. Clin Genet 64:497-501.
29. Phelan MC, Rogers RC, Clarkson KB, Bowyer FP, Levine MA, Estabrooks LL, Severson MC, Dobyns WB. 1995. Albright hereditaryosteodystrophy and del(2) (q37.3) in four unrelated individuals. Am J Med Genet 58:1-7.
30. Philippe A, Martinez M, Guilloud-Bataille M, Gillberg C, Rastam M, Sponheim E, Coleman M, Zappella M, Aschauer H, Van Maldergem L, Penet C, Feingold J, Brice A, Leboyer M, van Malldergerme L. 1999. Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study. Hum Mol Genet 8:805-812.
31. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo WL, Chen C, Zhai Y, Dairkee SH, Ljung BM, Gray JW, Albertson DG. 1998. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20: 207-211.
32. Rhiner C, Hengartner MO. 2006. Sugar antennae for guidance signals: syndecans and glypicans integrate directional cues for navigating neurons. Sci World J 6:1024-1036.
33. Rutter J, Michnoff CH, Harper SM, Gardner KH, McKnight SL. 2001. PAS kinase: an evolutionarily conserved PAS domain-regulated serine/thre- onine kinase. Proc Natl Acad Sci USA 98:8991-8996.
34. Shao Y, Wolpert CM, Raiford KL, Menold MM, Donnelly SL, Ravan SA, Bass MP, McClain C, von Wendt L, Vance JM, Abramson RH, Wright HH, Ashley-Koch A, Gilbert JR, DeLong RG, Cuccaro ML, Pericak-Vance MA. 2002. Genomic screen and follow-up analysis for autistic disorder. Am J Med Genet 114:99-105.
35. Shrimpton A, Braddock B, Thomson L, Stein C, Hoo J. 2004. Molecular delineation of deletions on 2q37.3 in three cases with an Albright hereditary osteodystrophy-like phenotype. Clin Genet 66:537-544.
36. Smith M, Escamilla JR, Filipek P, Bocian ME, Modahl C, Flodman P, Spence MA. 2001. Molecular genetic delineation of 2q37.3 deletion in autism and osteodystrophy: report of a case and of new markers for deletion screening by PCR. Cytogenet Cell Genet 94:15-22.
37. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Dohner H, Cremer T, Lichter P. 1997. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 20:399-407.
38. Toyofuku T, Yoshida J, Sugimoto T, Zhang H, Kumanogoh A, Hori M, Kikutani H. 2005. FARP2 triggers signals for Sema3A-mediated axonal repulsion. Nat Neurosci 8:1712-1719.
39. Ushiro H, Tsutsumi T, Suzuki K, Kayahara T, Nakano K. 1998. Molecular cloning and characterization of a novel Ste20-related protein kinase enriched in neurons and transporting epithelia. Arch Biochem Biophys 355:233-240.
40. Vorstman JA, Staal WG, van Daalen E, van Engeland H, Hochstenbach PF, Franke L. 2006. Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism. Mol Psychiatry 11:18-28.
41. Wang HC, FedoroffS. 1972. Banding in human chromosomes treated with trypsin. Nat New Biol 235:52-54.
42. Wilson LC, Leverton K, Oude Luttikhuis ME, Oley CA, Flint J, Wolsten- holme J, Duckett DP, Barrow MA, Leonard JV, Read AP, Trembath RC. 1995. Brachydactyly and mental retardation: an Albright hereditary osteodystrophy-like syndrome localized to 2q37. Am J Hum Genet 56:400-407.
43. Wolff DJ, Clifton K, Karr C, Charles J. 2002. Pilot assessment of the subtelomeric regions of children with autism: detection of a 2q deletion. Genet Med 4:10-14.
44. Yonekawa Y, Harada A, Okada Y, Funakoshi T, Kanai Y, Takei Y, Terada S, Noda T, Hirokawa N. 1998. Defect in synaptic vesicle precursor transport and neuronal cell death in KIF1A motor protein-deficient mice. J Cell Biol 141:431-441.
45. Zielinski B, Gratias S, Toedt G, Mendrzyk F, Stange DE, Radlwimmer B, Lohmann DR, Lichter P. 2005. Detection ofchromosomal imbalances in retinoblastoma by matrix-based comparative genomic hybridization. Genes Chromosomes Cancer 43:294-301.